Navigation Links
Cone-beam CT: Just as useful as MDCT before and after percutaneous vertebroplasty
Date:11/3/2008

Cone-beam CT which is believed to deliver less radiation than MDCT is just as useful when evaluating patients before and after percutaneous vertebroplasty according to a study performed at the Department of Clinical Radiology, Kyushu University, Fukoka, Japan. Percutaneous vertebroplasty is a minimally invasive cement augmentation technique to relieve pain in the back that is non-responsive to conservative treatment.

The study included 22 patients who had osteoporotic compression fractures and underwent percutaneous vertebroplasty for treatment. During the study cone-beam CT and MDCT were performed on all patients before and after percutaneous vertebroplasty. Before vertebroplasty, all 75 cortical defects seen on MDCT were also observed on cone-beam CT with 100% sensitivity and specificity. After vertebroplasty, MDCT found cement leakages in 17 disk spaces, 15 paravertebral soft tissues and 12 veins; cone-beam CT identified all cement leakages.

"While there is no gross difference between MDCT and cone-beam CT, cone-beam CT is believed to deliver less radiation," said Akio Hiwatashi, MD, lead author of the study.

Percutaneous vertebroplasty is common throughout the United States and European countries. It is often used when conservative treatments like pain medication, activity limitation, physical therapy and bracing is not enough.

"Patients can be safely evaluated before and after vertebroplasty using the cone-beam CT system. It is a technical advance in image guided intervention," said Dr. Hiwatashi.


'/>"/>

Contact: Heather Curry
hcurry@arrs.org
703-858-4304
American Roentgen Ray Society
Source:Eurekalert

Page: 1

Related medicine news :

1. Cone-Beam CT faster, potentially more accurate than conventional mammography
2. Study reports Double Balloon Endoscopy useful for diagnosis and treatment of obscure GI bleeding
3. A useful imaging modality for monitoring treatment response to hepatocellular carcinoma
4. CT useful and effective when diagnosing patients with large bowel obstruction
5. Researchers find mass media campaigns useful
6. Angina drug potentially useful against heart rhythm disorders
7. Zebrafish provide useful screening tool for genes, drugs that protect against hearing loss
8. Cause of effectiveness discovered for a cirrhosis treatment useful in 40 percent of patients
9. Robotic device appears useful for surgical removal of cancer involving the tonsils
10. PET scans useful for some cancer treatment, but how do patients fare?
11. CAD plus MDCT useful in finding lung nodules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... , ... April 24, 2017 , ... ... they are seeking public support to bring their novel lifesaving device for the ... device packed with medical-grade sensors, specially designed to read a child’s vital signs, ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... expected to be diagnosed globally; approximately 25,000 of them will be malignant.(1) As ... use of this type of healthcare model in the diagnosis and treatment of ...
(Date:4/24/2017)... Montclair, NJ (PRWEB) , ... April 24, 2017 , ... ... International Plaza Hotel, 4200 Jim Walter Blvd, for an educational and exciting 2-day program. ... all of our staff hearing this before they approach patients” about the course entitled ...
(Date:4/24/2017)... ... ... “Learning to Use Your SPIRITUAL COMPASS To Navigate Life Issues”: a guide to ... Navigate Life Issues” is the creation of published author, Rachel Jamerson, writer of 25 ... CONTACT USA, and former member of the American Association of Christian Counselors. Rachel ...
(Date:4/24/2017)... ... April 24, 2017 , ... Anaconda BioMed, a pre-clinical ... for the treatment of Acute Ischemic Stroke (AIS), today announced it has appointed ... product advances towards regulatory and clinical phases. , "This is another important step ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017 Research and Markets ... Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key ... to their offering. ... global pharmacogenomics market was valued at US$ 7,167.6 Mn in ... 2024, expanding at a CAGR of 5.6% from 2016 to ...
(Date:4/20/2017)... 20, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... positive preclinical results demonstrating anti-fibrotic effects with ... steatohepatitis (NASH), in an additional well-validated experimental ... has previously shown similar anti-fibrotic effects in ... scientists present novel data demonstrating anti-fibrotic effects ...
(Date:4/19/2017)... 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the ... Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Chief Executive Officer of the Company is scheduled to present on ... Bear and the Chairman of the Board, Tony Holler ... ...
Breaking Medicine Technology: